BT cuts annual revenue forecast – what's next for the telecoms giant?
BT has trimmed its sales forecast, but the overall outlook remains positive and big investors have bought in. Should you invest?
The “weak” performance of BT’s “problem child” business unit is still hampering CEO Allison Kirkby’s turnaround plan, says Jillian Deutsch on Bloomberg. BT was forced to cut its sales forecast for the year to 31 March 2025 by between 1% and 2% on 7 November. This was caused by a 6.8% adjusted revenue decline in the division serving business customers. As a result, overall second-quarter revenue fell 3% to £5.09 billion, below analysts’ expectations of £5.23 billion. BT’s shares promptly slipped by 5%.
It’s not surprising that BT’s business unit isn’t doing very well, says Hargreaves Lansdown’s Matt Britzman. Higher expenses and “a tough competitive landscape make it a tricky place to operate”. But investors can console themselves that profit and cash-flow guidance has been “left untouched”. What’s more, as the fibre rollout gathers pace, BP is not only “benefiting from higher prices and a more favourable mix of fibre versus older technology”, but also from the prospect of an end to the “massive investment” the rollout involves. Expect a major improvement” in areas such as cash flow.
Should investors buy BT?
Hopes that “once the digging has finished and 5G investment has been made”, BT can become a “strongly cash-generative provider of critical 21st-century infrastructure” will have been bolstered by Kirby’s determination to “rein in the foreign adventures and concentrate on the UK”, says Nils Pratley in The Guardian. While BT’s international operations comprise only a sixth of the company, they are a “sprawl” that spans 180 countries, and have been responsible for two destabilising profit warnings in 2008 and 2017. Still, selling these operations “won’t be easy”, with a series of “part-sales, partnerships and fiddly structures” a more likely option than “a neat sale of the whole shebang at a nice price”.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
It’s certainly “easier to earmark disposals than to snuffle out buyers”, says Lex in the Financial Times. So BT may have to settle for raising “a few hundred million here and there” from sales over an extended period of time. But some companies may be interested in the unwanted elements of BT, including rivals and private equity. Partial sales such as joint ventures are another option. What’s more, shareholders should take heart from the fact that Kirkby does have form when it comes to such “complicated clear-outs”. She oversaw a similar process at Sweden’s Telia.
BT has reportedly hired bankers to sell financial services unit Radianz, says Rupert Neate in The Sunday Times. Overall, investors have been “impressed” by Kirkby, especially her progress on broadband, as well as her determination to push through a savings drive that could see 55,000 jobs go by the end of the decade. While many feel that markets are still “stubbornly” refusing to price in the full impact of future cash flows, the share price has soared 27% in her 10-month tenure, with prominent investors, such as Carlos Slim and Sunil Mittal, taking major stakes.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

-
Polar Capital: a cheap, leveraged play on technologyPolar Capital has carved out a niche in fund management and is reaping the benefits
-
Vaccines inject billions into Big Pharma – how to profitThe vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
Polar Capital: a cheap, leveraged play on technologyPolar Capital has carved out a niche in fund management and is reaping the benefits
-
Vaccines inject billions into Big Pharma – how to profit from the sectorThe vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors
-
'Investors should keep putting their trust in investment trusts'Interview Peter Walls, manager of the Unicorn Mastertrust fund, analyses investment trusts in a conversation with Andrew Van Sickle
-
Monks Investment Trust is worthy of the spotlightMonks Investment Trust, a global growth trust, sits in the shadow of its stablemate, Scottish Mortgage. But its record warrants attention, says Max King
-
New year, same market forecastsForecasts from banks and brokers are as bullish as ever this year, but there is less conviction about the US, says Cris Sholto Heaton
-
'Expect more policy U-turns from Keir Starmer'Opinion Keir Starmer’s government quickly changes its mind as soon as it runs into any opposition. It isn't hard to work out where the next U-turns will come from
-
Why does Donald Trump want Venezuela's oil?The US has seized control of Venezuelan oil. Why and to what end?
-
Britain heads for disaster – what can be done to fix our economy?Opinion The answers to Britain's woes are simple, but no one’s listening, says Max King